Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01835145
What this trial is testing

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Uveal MelanomaStage III Uveal Melanoma AJCC v7Stage IIIA Uveal Melanoma AJCC v7+3 more
National Cancer Institute (NCI) 47
Early research (Phase 1)Study completedNCT01462773
What this trial is testing

Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma

Who this might be right for
Melanoma
Ohio State University Comprehensive Cancer Center 16
Not applicableStudy completedNCT05102773
What this trial is testing

The Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma Patients

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Pathologic Stage IV Cutaneous Melanoma AJCC v8
Ohio State University Comprehensive Cancer Center 88
Not applicableStudy completedNCT03879395
What this trial is testing

Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study

Who this might be right for
Melanoma Stage IvMelanoma MetastaticAbdominal Tumor
Vastra Gotaland Region 15
Not applicableLooking for participantsNCT02828202
What this trial is testing

Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Who this might be right for
Malignant Melanoma
Assistance Publique - Hôpitaux de Paris 6,000
Testing effectiveness (Phase 2)Study completedNCT00257465
What this trial is testing

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Who this might be right for
Melanoma
AVAX Technologies 82
Testing effectiveness (Phase 2)Study completedNCT00847106
What this trial is testing

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 15
Early research (Phase 1)Ended earlyNCT00585000
What this trial is testing

Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma

Who this might be right for
Melanoma
AstraZeneca 49
Testing effectiveness (Phase 2)Study completedNCT02076633
What this trial is testing

Intratumoral Administration of L19IL2/L19TNF

Who this might be right for
Malignant Melanoma, Skin
Philogen S.p.A. 21
Testing effectiveness (Phase 2)WithdrawnNCT01216787
What this trial is testing

RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery

Who this might be right for
Stage IIIB MelanomaStage IIIC MelanomaStage IV Melanoma
National Cancer Institute (NCI)
Not applicableStudy completedNCT03518814
What this trial is testing

Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)

Who this might be right for
Melanoma (Skin) Stage IVRemission
Lille Catholic University 40
Large-scale testing (Phase 3)Ended earlyNCT00020839
What this trial is testing

Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain

Who this might be right for
Melanoma (Skin)Metastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 23
Testing effectiveness (Phase 2)Study completedNCT01133977
What this trial is testing

E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma

Who this might be right for
Stage IV Melanoma
Eisai Inc. 97
Testing effectiveness (Phase 2)Looking for participantsNCT03340129
What this trial is testing

Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

Who this might be right for
Melanoma Stage Iv
Melanoma Institute Australia 218
Testing effectiveness (Phase 2)Study completedNCT00204594
What this trial is testing

Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 1
Very early researchStudy completedNCT02652455
What this trial is testing

Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

Who this might be right for
Melanoma (Skin)Skin Cancer
H. Lee Moffitt Cancer Center and Research Institute 11
Testing effectiveness (Phase 2)Looking for participantsNCT07686835
What this trial is testing

Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.

Who this might be right for
Melanoma (Skin) Stage IVMelanoma (Skin Cancer)Melanoma Metastatic+2 more
Radboud University Medical Center 70
Testing effectiveness (Phase 2)Study completedNCT04526899
What this trial is testing

Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVUnresectable Melanoma
BioNTech SE 184
Early research (Phase 1)Study completedNCT00349206
What this trial is testing

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Who this might be right for
MelanomaRecurrent MelanomaStage III Melanoma+1 more
National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)UnknownNCT00085397
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Dana-Farber Cancer Institute 40
Next Page